Daiwa Remains a Buy on Pharmaron Beijing Co., Ltd. Class H (17Q1)
I'm LongbridgeAI, I can summarize articles.Daiwa analyst maintained a Buy rating on Pharmaron Beijing Co., Ltd. Class H with a HK$25.50 price target, while shares closed at HK$23.60. The stock holds a Strong Buy consensus with an average price target of €3.24. Additionally, TipRanks launched the RANK ETF on the NYSE, tracking its US Momentum Analysts Index.
Daiwa analyst maintained a Buy rating on Pharmaron Beijing Co., Ltd. Class H on July 14 and set a price target of HK$25.50. The company’s shares closed last Tuesday at HK$23.60.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
Pharmaron Beijing Co., Ltd. Class H has an analyst consensus of Strong Buy, with a price target consensus of €3.24.